ClinicalTrials.Veeva

Menu

The Effectiveness of Intravitreal Avastin Injection for CRVO

Z

Ziv Hospital

Status

Unknown

Conditions

Central Retinal Vein Occlusion

Study type

Observational

Funder types

Other

Identifiers

NCT01678248
0048-12-ZIV

Details and patient eligibility

About

to determine the effectivness of intravitreal avastin injection on visual acuity on people that suffer from central retinal vein occlusion

Enrollment

68 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients above 18 years old
  • suffer from CRVO
  • maximal visual acuity 6/15

Exclusion criteria

  • VA of LP
  • retinal disease other than CRVO
  • incomplete medical record
  • follow up less than 6 months

Trial contacts and locations

1

Loading...

Central trial contact

Joseph pikkel, M.D; Otzem Chassid, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems